Latest radiation therapy Stories
NEW YORK, Feb. 15, 2013 /PRNewswire/ -- Staying ahead of the curve often comes with a price. In the case of prostate cancer, treatment innovations fuel ongoing debate over the cost-benefit analysis of new technologies and modalities. In an institution-based study led by Dr. David Samadi, Vice Chairman, Department of Urology and Chief of Robotics and Minimally Invasive Surgery at The Mount Sinai Medical Center in New York, Robotic-Assisted Laparoscopic Prostatectomy (RALP) was found...
HOUSTON, Feb. 14, 2013 /PRNewswire/ -- Castle Biosciences Inc., a leading developer of prognostic tests for rare cancers, announced today the launch of MyUvealMelanoma.com, a website created to educate newly diagnosed patients, their families and healthcare providers about the most common form of eye cancer. MyUvealMelanoma tells the story of this disease, its treatment and the importance of prognostic testing, through the experience of patients who recently faced this devastating...
SAN DIEGO, Feb. 14, 2013 /PRNewswire/ -- GenomeDx Biosciences today announced new data supporting the clinical validation and utility of Decipher(TM), a transformative genomic test that forecasts risk of metastasis in men with prostate cancer. An analysis of men at risk of recurrence after prostate cancer surgery showed Decipher was a better predictor of metastasis than conventional risk assessment tools such as PSA, tumor stage and grade. A separate study found that the more...
Prostate Cancer Report to be released at National Proton Conference in Washington, DC WASHINGTON, Feb. 13, 2013 /PRNewswire-USNewswire/ -- Ninety-nine percent of proton therapy patients believe they made the best treatment decision for themselves, according to a new data analysis of outcomes and satisfaction of prostate cancer patients. The survey released today is the most comprehensive of its kind to capture health-related quality of life measures for proton therapy, an advanced...
An international study coordinated at the IRCM finds a possible alternative treatment to significantly reduce the adverse effects of chemotherapy An international research team coordinated at the IRCM in Montréal found a possible alternative treatment for lymphoid leukemia. Led by Dr. Tarik Möröy, the IRCM’s President and Scientific Director, the team discovered a molecule that represents the disease’s “Achilles’ heel” and could be targeted to develop a new approach that would...
PORTLAND, Ore., Feb. 11, 2013 /PRNewswire/ -- Shriners Hospitals for Children-Portland announces the availability of the new EOS® Imaging System, the first technology capable of providing full-body images of patients in a natural standing or sitting position, in 3D and with a low radiation dose. At the Portland Shriners Hospitals for Children more than 10,000-12,000 radiological images are taken each year of its 6,000 active patients. More than 40% of the X-rays taken are of...
GILBERT, Ariz., Feb. 7, 2013 /PRNewswire/ -- Banner MD Anderson Cancer Center (Gilbert, Arizona, USA) recently acquired Elekta cancer management solutions, including two Elekta Infinity(TM) radiation therapy systems, each with an Agility(TM)* 160-leaf multileaf collimator (MLC) and a HexaPOD(TM) patient positioning system. The center also purchased new modules for its MOSAIQ® Oncology Information System and Clarity® Soft Tissue Visualization system for image guided radiation...
Researchers are improving the performance of technologies ranging from medical CT scanners to digital cameras using a system of models to extract specific information from huge collections of data and then reconstructing images like a jigsaw puzzle. The new approach is called model-based iterative reconstruction, or MBIR. "It's more-or-less how humans solve problems by trial and error, assessing probability and discarding extraneous information," said Charles Bouman, Purdue University's...
NEW YORK, Feb. 5, 2013 /PRNewswire/ -- A new Prostate Cancer Outcomes Study (PCOS) in the January 31, 2013 New England Journal of Medicine, http://www.nejm.org/doi/full/10.1056/NEJMoa1209978 reported the functional status of men after robotic prostate surgery and external-beam radiation therapy (EBRT) for localized prostate cancer. Most men in the study (now ages 70-89) reported some problems with urinary control and sex after treatment for prostate cancer. Long-term side effects,...
RICHLAND, Wash., Feb. 5, 2013 /PRNewswire/ -- IsoRay Inc. (AMEX: ISR), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications, today announced the presentation video by Cornell Weill demonstrating their techniques in the successful treatment of metastatic brain cancers using IsoRay's patented Cesium-131 (Cs-131) sutured seeds. Dr. Theodore H. Schwartz and Dr. Gabriella Wernicke, both of Weill Cornell Medical Center, presented their...
